RUBICON RESEARCH LIMITED — Investor Relations & Filings

Rubicon Research Limited is a specialty organization focused on formulation development and the commercialization of value-added products. The company leverages proprietary drug delivery technology platforms to develop complex oral solids, liquids, topicals, and sterile dosage forms. Its core business activities encompass contract research and manufacturing services alongside the development of a diverse portfolio of Abbreviated New Drug Applications. The firm operates advanced research and development centers and manufacturing facilities that comply with stringent international regulatory standards. Rubicon Research emphasizes innovation in life cycle management and the enhancement of existing molecules to improve patient compliance and therapeutic outcomes. Its operations provide end-to-end solutions from initial concept and formulation design to commercial-scale production, serving global markets with a focus on high-quality, technology-driven solutions.